263 related articles for article (PubMed ID: 24934184)
1. Drug repurposing based on drug-drug interaction.
Zhou B; Wang R; Wu P; Kong DX
Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing with network reinforcement.
Nam Y; Kim M; Chang HS; Shin H
BMC Bioinformatics; 2019 Jul; 20(Suppl 13):383. PubMed ID: 31337333
[TBL] [Abstract][Full Text] [Related]
4. GES polypharmacology fingerprints: a novel approach for drug repositioning.
Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
[TBL] [Abstract][Full Text] [Related]
5. A Drug Repurposing Method Based on Drug-Drug Interaction Networks and Using Energy Model Layouts.
Udrescu M; Udrescu L
Methods Mol Biol; 2019; 1903():185-201. PubMed ID: 30547443
[TBL] [Abstract][Full Text] [Related]
6. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
Iwata H; Sawada R; Mizutani S; Yamanishi Y
J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
[TBL] [Abstract][Full Text] [Related]
7. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
Guney E
Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
[TBL] [Abstract][Full Text] [Related]
8. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
Kissa M; Tsatsaronis G; Schroeder M
Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
[TBL] [Abstract][Full Text] [Related]
10. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering.
Shi JY; Yiu SM; Li Y; Leung HC; Chin FY
Methods; 2015 Jul; 83():98-104. PubMed ID: 25957673
[TBL] [Abstract][Full Text] [Related]
11. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
Zong N; Wong RSN; Ngo V
Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
[TBL] [Abstract][Full Text] [Related]
12. Identify drug repurposing candidates by mining the protein data bank.
Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
[TBL] [Abstract][Full Text] [Related]
13. A Computational Bipartite Graph-Based Drug Repurposing Method.
Zheng S; Ma H; Wang J; Li J
Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
[TBL] [Abstract][Full Text] [Related]
14. Design of a tripartite network for the prediction of drug targets.
Kunimoto R; Bajorath J
J Comput Aided Mol Des; 2018 Feb; 32(2):321-330. PubMed ID: 29340865
[TBL] [Abstract][Full Text] [Related]
15. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing and adverse event prediction using high-throughput literature analysis.
Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
[TBL] [Abstract][Full Text] [Related]
17. Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses.
Paik H; Chen B; Sirota M; Hadley D; Butte AJ
CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):599-607. PubMed ID: 27860440
[TBL] [Abstract][Full Text] [Related]
18. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
19. Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities.
Jhamb D; Magid-Slav M; Hurle MR; Agarwal P
Drug Discov Today; 2019 Jun; 24(6):1232-1236. PubMed ID: 30935985
[TBL] [Abstract][Full Text] [Related]
20. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
